Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$0.28 - $0.44 $192 - $302
-687 Reduced 34.49%
1,305 $1,000
Q3 2022

Nov 09, 2022

BUY
$0.28 - $0.41 $192 - $281
687 Added 52.64%
1,992 $1,000
Q2 2022

Aug 05, 2022

BUY
$0.25 - $0.73 $326 - $952
1,305 New
1,305 $0

Others Institutions Holding SIOX

About Sio Gene Therapies Inc.


  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.